About Spectra Biomedical
Discovering and developing novel pharmaceuticals to treat neuropsychiatric and other multifactorial diseases. The unmet therapeutic needs of neuropsychiatric disorders alone have been estimated to represent an annual market potential of more than five billion dollars. Spectra believes that it can generate important pharmaceutical products for this market by applying molecular genetic technologies to clinically evaluated human DNA databases. The company has identified families that are willing to cooperate on the analysis of various disorders over a prolonged period of time. These familial samples can also be used to determine the clinical relevance of newly discovered genes. Taking this approach, Spectra has identified novel targets for the discovery of new diagnostics and therapeutics for migraine, depression, and other diseases.
Missing: Spectra Biomedical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Spectra Biomedical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Spectra Biomedical Frequently Asked Questions (FAQ)
When was Spectra Biomedical founded?
Spectra Biomedical was founded in 1993.
Where is Spectra Biomedical's headquarters?
Spectra Biomedical's headquarters is located at 4040 Campbell Avenue, Menlo Park.
What is Spectra Biomedical's latest funding round?
Spectra Biomedical's latest funding round is Acquired.
How much did Spectra Biomedical raise?
Spectra Biomedical raised a total of $2.5M.
Who are the investors of Spectra Biomedical?
Investors of Spectra Biomedical include Glaxo Wellcome, Avalon Ventures and Institutional Venture Partners.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.